Literature DB >> 31567596

Defining Low-threshold Buprenorphine Treatment.

Andrea Jakubowski1, Aaron Fox.   

Abstract

: Buprenorphine treatment for opioid use disorder is safe and effective, but only a fraction of Americans who need treatment receive it. One reason for this is that many buprenorphine treatment programs have rigid requirements for entry and continuation, limiting the number of people who receive treatment. "Low-threshold treatment" is a term used to describe an alternative approach that attempts to remove as many barriers to treatment as possible. However, few studies have described its essential features. In this article, we define low-threshold treatment and propose the approach be guided by the following principles: same-day treatment entry; harm-reduction approach; flexibility; and wide availability in places where people with opioid use disorder go. We discuss the evidence and rationale for these principles and directions for future research.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31567596      PMCID: PMC7075734          DOI: 10.1097/ADM.0000000000000555

Source DB:  PubMed          Journal:  J Addict Med        ISSN: 1932-0620            Impact factor:   4.647


  20 in total

1.  Changes in Substance Abuse Treatment Use Among Individuals With Opioid Use Disorders in the United States, 2004-2013.

Authors:  Brendan Saloner; Shankar Karthikeyan
Journal:  JAMA       Date:  2015-10-13       Impact factor: 56.272

Review 2.  Maintenance medication for opiate addiction: the foundation of recovery.

Authors:  Gavin Bart
Journal:  J Addict Dis       Date:  2012

Review 3.  Unobserved "home" induction onto buprenorphine.

Authors:  Joshua D Lee; Frank Vocci; David A Fiellin
Journal:  J Addict Med       Date:  2014 Sep-Oct       Impact factor: 3.702

Review 4.  The Role of Behavioral Interventions in Buprenorphine Maintenance Treatment: A Review.

Authors:  Kathleen M Carroll; Roger D Weiss
Journal:  Am J Psychiatry       Date:  2016-12-16       Impact factor: 18.112

5.  Opioid maintenance treatment as a harm reduction tool for opioid-dependent individuals in New York City: the need to expand access to buprenorphine/naloxone in marginalized populations.

Authors:  Sharon Stancliff; Herman Joseph; Chunki Fong; Terry Furst; Sandra D Comer; Perrine Roux
Journal:  J Addict Dis       Date:  2012

6.  Treating homeless opioid dependent patients with buprenorphine in an office-based setting.

Authors:  Daniel P Alford; Colleen T LaBelle; Jessica M Richardson; James J O'Connell; Carole A Hohl; Debbie M Cheng; Jeffrey H Samet
Journal:  J Gen Intern Med       Date:  2007-02       Impact factor: 5.128

Review 7.  Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies.

Authors:  Luis Sordo; Gregorio Barrio; Maria J Bravo; B Iciar Indave; Louisa Degenhardt; Lucas Wiessing; Marica Ferri; Roberto Pastor-Barriuso
Journal:  BMJ       Date:  2017-04-26

8.  Public sector low threshold office-based buprenorphine treatment: outcomes at year 7.

Authors:  Elenore Patterson Bhatraju; Ellie Grossman; Babak Tofighi; Jennifer McNeely; Danae DiRocco; Mara Flannery; Ann Garment; Keith Goldfeld; Marc N Gourevitch; Joshua D Lee
Journal:  Addict Sci Clin Pract       Date:  2017-02-28

Review 9.  Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and meta-analysis.

Authors:  Georgie J MacArthur; Silvia Minozzi; Natasha Martin; Peter Vickerman; Sherry Deren; Julie Bruneau; Louisa Degenhardt; Matthew Hickman
Journal:  BMJ       Date:  2012-10-03

10.  Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users.

Authors:  Charlotte Van Den Berg; Colette Smit; Giel Van Brussel; Roel Coutinho; Maria Prins
Journal:  Addiction       Date:  2007-09       Impact factor: 6.526

View more
  23 in total

1.  Retention of Patients With Multiple Vulnerabilities in a Federally Qualified Health Center Buprenorphine Program: Pennsylvania, 2017-2018.

Authors:  Lara Carson Weinstein; Qais Iqbal; Amy Cunningham; Robin Debates; Greg Landistratis; Patrick Doggett; Alexis Silverio
Journal:  Am J Public Health       Date:  2020-02-20       Impact factor: 9.308

2.  The Experience of Implementing a Low-Threshold Buprenorphine Treatment Program in a Non-Urban Medical Practice.

Authors:  Shashi N Kapadia; Judith L Griffin; Justine Waldman; Nicolas R Ziebarth; Bruce R Schackman; Czarina N Behrends
Journal:  Subst Use Misuse       Date:  2021-12-10       Impact factor: 2.164

3.  Sexually Transmitted and Blood-borne Infections Among Patients Presenting to a Low-barrier Substance Use Disorder Medication Clinic.

Authors:  Leah Harvey; Jessica L Taylor; Sabrina A Assoumou; Jessica Kehoe; Elissa M Schechter-Perkins; Edward Bernstein; Alexander Y Walley
Journal:  J Addict Med       Date:  2021 Nov-Dec 01       Impact factor: 3.702

4.  Optimizing opioid use disorder treatment with naltrexone or buprenorphine.

Authors:  Kara E Rudolph; Iván Díaz; Sean X Luo; John Rotrosen; Edward V Nunes
Journal:  Drug Alcohol Depend       Date:  2021-09-11       Impact factor: 4.492

5.  A mixed methods study of provider factors in buprenorphine treatment retention.

Authors:  Alex K Gertner; Hannah Margaret Clare; Byron J Powell; Allison R Gilbert; Hendree E Jones; Pam Silberman; Christopher M Shea; Marisa Elena Domino
Journal:  Int J Drug Policy       Date:  2022-05-06

6.  "It wasn't here, and now it is. It's everywhere": fentanyl's rising presence in Oregon's drug supply.

Authors:  Sarah S Shin; Kate LaForge; Erin Stack; Justine Pope; Gillian Leichtling; Jessica E Larsen; Judith M Leahy; Andrew Seaman; Daniel Hoover; Laura Chisholm; Christopher Blazes; Robin Baker; Mikaela Byers; Katie Branson; P Todd Korthuis
Journal:  Harm Reduct J       Date:  2022-07-11

7.  "The Doctor Says You Cannot Have [Buprenorphine]" Autonomy and Use of Prescribed or Non-Prescribed Buprenorphine.

Authors:  Benjamin T Hayes; Andrea Jakubowski; Christine Fitzsimmons; Billy Garcia; Franklin Ramirez; Aaron D Fox
Journal:  Subst Use Misuse       Date:  2021-05-03       Impact factor: 2.164

8.  Patients at a drug detoxification center share perspectives on how to increase hepatitis C treatment uptake: A qualitative study.

Authors:  Sabrina A Assoumou; Carlos R Sian; Christina M Gebel; Benjamin P Linas; Jeffrey H Samet; Judith A Bernstein
Journal:  Drug Alcohol Depend       Date:  2021-01-11       Impact factor: 4.492

Review 9.  A Critical Review of the Social and Behavioral Contributions to the Overdose Epidemic.

Authors:  Magdalena Cerdá; Noa Krawczyk; Leah Hamilton; Kara E Rudolph; Samuel R Friedman; Katherine M Keyes
Journal:  Annu Rev Public Health       Date:  2021-11-30       Impact factor: 21.981

10.  CommunityStat: A Public Health Intervention to Reduce Opioid Overdose Deaths in Burlington, Vermont, 2017-2020.

Authors:  Brandon Del Pozo
Journal:  Contemp Drug Probl       Date:  2021-10-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.